secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001683168-26-000205
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals files updated investor presentation; no specific financial or operational details disclosed
--------------------------------------------------------------------------------

- Filing includes an updated investor presentation as of January 2026, furnished as Exhibit 99.1.
- The presentation content is not fully provided; only legal disclaimers are visible in the filing.
- No new financial results, guidance, or material events are disclosed in the filing text.
- The presentation may contain updates on commercial progress, but specifics are not available from this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316826000205/0001683168-26-000205-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316826000205/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-000205

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer